Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 1/20 | 0.82 |
| ▸ | NT5E | P21589 | 1/20 | 0.77 |
| ▸ | KRAS | P01116 | 5/20 | 0.74 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.73 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.69 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.69 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.69 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.69 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.67 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.67 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.67 |
| ▸ | IMPDH2 | P12268 | 5/20 | 0.66 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.66 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.66 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.66 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.66 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17072523 | 1.00 | TGM2 (0.82) | TGM2NT5EKRASFUT5P2RX3 | |
| SCHEMBL80058 | 1.00 | TGM2 (0.82) | TGM2NT5EKRASFUT5P2RX3 | |
| SCHEMBL37405 | 1.00 | TGM2 (0.82) | TGM2NT5EKRASFUT5P2RX3 | |
| SCHEMBL13210265 | 1.00 | TGM2 (0.82) | TGM2NT5EKRASFUT5P2RX3 | |
| SCHEMBL18775378 | 1.00 | TGM2 (0.82) | TGM2NT5EKRASFUT5P2RX3 | |
| SCHEMBL23969756 | 1.00 | TGM2 (0.82) | TGM2NT5EKRASFUT5P2RX3 | |
| Triphosphate SCHEMBL28597197 | 1.00 | TGM2 (0.82) | TGM2NT5EKRASFUT5P2RX3 | |
| SCHEMBL18785111 | 1.00 | TGM2 (0.82) | TGM2NT5EKRASFUT5P2RX3 | |
| Gtp SCHEMBL5809658 | 0.99 | TGM2 (0.81) | TGM2NT5EKRASFUT5P2RX3 | |
| SCHEMBL1304258 | 0.99 | TGM2 (0.81) | TGM2NT5EKRASFUT5P2RX3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1028 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4613852-A1 | METHOD FOR COUPLING THERAPEUTIC MOLECULES TO SURFACES OF MATURE ERYTHROCYTES AND USE | Ray Medicine Biotechnology Co., Ltd (CN) | 2025-09-10 | — | — | EP | claimed |
| US-20250243525-A1 | BIOCATALYTIC MANUFACTURE OF SUGAR NUCLEOTIDES | ZYMTRONIX CATALYTIC SYSTEMS, INC. (US) | 2025-07-31 | — | — | US | claimed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | claimed |
| CN-118165928-A | Serum-free medium for promoting mesenchymal stem cell derived exosomes, preparation and application | 华东理工大学 | 2024-06-11 | — | — | CN | claimed |
| US-20240158754-A1 | REDUCING HIGH MANNOSE GLYCAN PROTEIN EXPRESSION USING GUANOSINE 5'-MONOPHOSPHATE | MERCK SHARP & DOHME LLC (US) | 2024-05-16 | — | — | US | claimed |
| WO-2024087760-A1 | METHOD FOR COUPLING THERAPEUTIC MOLECULES TO SURFACES OF MATURE ERYTHROCYTES AND USE | 北京睿脉医药科技有限公司 | 2024-05-02 | — | — | WO | claimed |
| WO-2023250198-A1 | BIOCATALYTIC MANUFACTURE OF SUGAR NUCLEOTIDES | ZYMTRONIX CATALYTIC SYSTEMS, INC. (US) | 2023-12-28 | — | — | WO | claimed |
| US-11723934-B2 | Compositions and methods for the induction of CD8+ T-cells | KEIO UNIVERSITY (JP) | 2023-08-15 | — | — | US | claimed |
| CN-111351877-A | Tissue energy metabolism substance analysis method based on UPLC-MSMS | 上海中科新生命生物科技有限公司 | 2020-06-30 | — | — | CN | claimed |
| US-20170072097-A1 | INJECTABLE CHITOSAN SPONGES FOR ENHANCING BONE REGENERATION | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING / MCGILL UNIVERSITY (CA) | 2017-03-16 | — | — | US | claimed |
| US-20050130197-A1 | Homogeneous fluorescence polarization assay for high throughput screening | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (SNUIF) (KR) | 2005-06-16 | — | — | US | claimed |
| US-20050069953-A1 | Assay solution compositions and methods for GPCR arrays | CORNING INCORPORATED | 2005-03-31 | — | — | US | claimed |
| WO-2005014746-A1 | CMP SLURRY | NYACOL NANO TECHNOLOGIES, INC. (US) | 2005-02-17 | — | — | WO | claimed |
| EP-1005327-A1 | TARGETED LIPOSOMAL CONSTRUCTS FOR DIAGNOSTIC AND THERAPEUTIC USES | SDG, INC. (US) | 2000-06-07 | — | — | EP | claimed |
| EP-1000622-A2 | Antiviral agents | Fujirebio Inc. (JP) | 2000-05-17 | — | — | EP | claimed |
| US-6063400-A | CARRIER; DIAGNOSTIC OR THERAPEUTIC AGENT AND SEQUESTERING AGENT | SDG, INC. (US) | 2000-05-16 | — | — | US | claimed |
| WO-1999001110-A1 | TARGETED LIPOSOMAL CONSTRUCTS FOR DIAGNOSTIC AND THERAPEUTIC USES | SDG, INC. (US) | 1999-01-14 | — | — | WO | claimed |
| US-5770407-A | Process for preparing nucleotide inhibitors of glycosyltransferases | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-06-23 | — | — | US | claimed |
| US-5741635-A | DETERMINATION OF RAS-BOUND GTP LEVELS USEFUL AS A SCREENING METHOD FOR REGULATION OF G PROTEIN ACTIVATION IN MAMMALIAN CELLS AND TISSUES | MOUNT SINAI HOSPITAL CORPORATION (CA) | 1998-04-21 | — | — | US | claimed |
| EP-0577266-A2 | Method for preparing (gamma-32p) labeled nucleotides by enzymatic conversion of dihydroxyacetone phosphate to 3-phosphoglycerate | ICN BIOMEDICALS INC. (US) | 1994-01-05 | — | — | EP | claimed |